DIA 2013 49th Annual Meeting
Click here to go to the previous page
The New Standards for the Identification of Medicinal Products and Individual Case Safety Reporting Applied in Pharmacovigilance
Track : Track 14: Clinical Safety and Pharmacovigilance
Program Code: 141
Date: Monday, June 24, 2013
Time: 2:30 PM to 4:00 PM  EST
Location: 157AB
CHAIR :
 Sabine Brosch, PharmD,PhD (SCHAGY), Business Lead, EudraVigilance and International Standardisation in PhV, European Medicines Agency, European Union, United Kingdom
SPEAKER (S):
 Lise R. Stevens, (SPKAGY), Project Manager, Bioinformatics Support Staff, CBER, FDA, United States
Konstas Kidos, MS (SPKNON), Oracle Corporation, United States
Description
The development of the international standards arising from the International Conference on Harmonization (ICH) of Technical Requirements for Registration of Pharmaceuticals for Human Use topics M5, Identification of Medicinal Products (IDMP) and E2B(R3), Data Elements for the Transmission of Individual Case Safety Reports, are close to finalization and implementation. In this session, attendees will hear about the status of the two related projects from an EMA and FDA perspective and the industry response to this work.